The largest database of trusted experimental protocols

Bl21 codonplus cells

Manufactured by Agilent Technologies
Sourced in United States

BL21-CodonPlus cells are an E. coli expression system designed to enhance the expression of proteins that contain rare codons. The cells provide increased levels of the tRNAs that recognize these rare codons, which can improve the expression of heterologous proteins.

Automatically generated - may contain errors

8 protocols using bl21 codonplus cells

1

Cardiac Tropomyosin Purification and Variant Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human cardiac tropomyosin was expressed in BL21‐CodonPlus cells (Agilent Technologies, Santa Clara, CA) and purified using established protocols.32, 33, 40, 41 On the day of the experiment, tropomyosin was reduced in 50 mmol/L of DTT at 56°C for 5 minutes, and aggregates were subsequently removed by ultracentrifugation at 436 000g in an Optima MAX‐TL Ultracentrifuge (Beckman Coulter, Brea, CA).42 The R94C variant was introduced into TNNT2 using the QuickChange Site‐Directed Mutagenesis kit (Agilent Technologies). Human troponins I, T, and C were expressed in BL21‐CodonPlus cells (Agilent Technologies), purified, and complexed using established protocols.43
+ Open protocol
+ Expand
2

Protein Expression of LmEutT Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
For protein expression, pTEV18 32 (link) vector-based plasmids encoding LmEutT variants were transformed into BL21-CodonPlus cells (Agilent) and grown as previously described.26 (link) For analysis of ACAT activity in vivo, pTAC-85 33 (link) vector-based plasmids encoding LmEutT variants were transformed into the reporter strain JE22174. Strains were grown in 1 mL of nutrient broth (NB, Difco) (8 g/L) containing NaCl (5 g/L) and were incubated overnight at 37 °C. These cultures were subcultured into minimal medium containing lactose as the sole source of carbon and energy, as described elsewhere.26 (link)
+ Open protocol
+ Expand
3

Expression and Purification of SARS-CoV-2 Mpro

Check if the same lab product or an alternative is used in the 5 most similar protocols
Escherichia coli (E. coli) BL21-CodonPlus cells (Agilent Technologies) were transformed with the plasmid pETM33_NSP5_Mpro (a gift from Ylva Ivarsson (Addgene plasmid #156475)) and the selected colony was inoculated in 100 mL of LB medium. Protein expression was induced by the addition of 0.1 mM isopropyl-β-D-thiogalactopyranoside (IPTG), followed by incubation at 37 °C for 2.3 h. The cells were harvested by centrifugation (4000× g, 10 min, 4 °C) and the pellet was resuspended in 10 mL lysis buffer (50 mM Tris (pH 8), 300 mM NaCl, 10 mM beta-mercaptoethanol (bME), 1 mM PMSF and 10% (v/v) glycerol), followed by sonication. The supernatant was collected after centrifugation (18,000× g, 90 min, 45 °C) and incubated with GSH beads at 4 °C for 2 h. The beads were washed (wash buffer—50 mM Tris (pH 7), 150 mM NaCl, 10 mM beta-mercaptoethanol (bME), 1 mM EDTA, 0.01% Triton X-100 and 10% glycerol) and incubated with PreScission Protease (GE Healthcare#27-0843-01) in cleavage buffer (50 mM Tris (pH 7), 150 mM NaCl, 1 mM DTT, 1 mM EDTA, 0.01% Triton X-100 and 10% glycerol) at 4 °C for 16 h. The supernatant containing Mpro was collected after centrifugation at 500× g at 4 °C for 10 min.
+ Open protocol
+ Expand
4

Purification and RNA Binding of SlDEAD39

Check if the same lab product or an alternative is used in the 5 most similar protocols
The complete open reading frame of the SlDEAD39 gene was amplified from the binary vector, pRokII, with primers listed in Table S1 and cloned in the pGEX4T‐3 expression vector. The resulting plasmid was introduced into E. coli BL21‐CodonPlus cells (Agilent) which, in turn, were grown to the exponential phase when the protein expression was induced by addition of IPTG to 1 mM and further incubation for 16 hr at 20°C. After bacteria disruption by sonication, protein purification was performed using reduced GST‐sepharose (Pharmacia) according to the manufacturer's instructions. The fusion protein was digested with thrombin, and the SlDEAD39 protein was eluted using 20 mM Tris–HCl buffer (pH 8.6), 100 mM NaCl, 0.3 mM CaCl2, 1 mM DTT and conserved at −20°C after addition of 50% glycerol. The RNA binding analysis was performed as described in Nishimura, Ashida, Ogawa and Yokota (2010) with synthetic ribonucleotides from the tomato 23S transcript, RNA5 5′‐ GCCCCGUAACUUCGGGAGAAGGGGUGCCUCCUCACAAAGGGGGU ‐3′ and RNA2 5′‐UGCCUCCUCACAAAGGGGGUC‐3′. The mobility of the complex was determined as described in Rio (2014).
+ Open protocol
+ Expand
5

Expression and Purification of Mouse ATE1-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The kanamycin-resistant pET29a(+) expression plasmid encoding for N-terminally tagged mouse (Mus musculus) ATE1-1 (Uniprot ID Q9Z2A5) was prepared as previously described33 (link). The expression plasmid was transformed into chemically competent BL21 Codon Plus cells (Agilent part # 230245), spread onto LB agar plates supplemented with 100 μg/mL kanamycin and 50 μg/mL chloramphenicol and grown overnight at 37 °C. Expression of MmATE1-1 was identical to that of ScATE1 (vide supra) and cells were grown in the presence of supplemented L-Cys and ferric citrate, as described (vide supra), except that the antibiotics kanamycin and chloramphenicol were supplemented to 100 and 50 μg/mL (final concentrations), respectively, instead of ampicillin. The purification of MmATE1-1 was identical to that of ScATE1 (vide supra).
+ Open protocol
+ Expand
6

Fab Protein Expression and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The coding sequences for the VL and VH regions of selected Fabs were cloned into a custom expression vector with protein expression driven by a ptac promoter, with a C-terminal 6xHis tag at the end of CH1 domain on heavy chain. Fab proteins were expressed in E. coli. BL21 Codon Plus cells (Agilent, Santa Clara, CA, USA). Actively growing cells (O.D. 0.8) were induced using 0.4 mM IPTG and incubated at 24 °C for 12 h. Cells were lysed and the fab proteins were purified from clarified lysate using Ni-NTA Sepharose resin (GE Healthcare) using manufacturer recommended protocols.
+ Open protocol
+ Expand
7

Purification of GST-CRM1 Fusion Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
The GST-CRM1 plasmid was kindly provided by Dr. Jorgen Kjems. E. Coli BL21 CodonPlus cells (Agilent Technologies) previously transformed by either GST-CRM1 or GST plasmid were induced with 1mM isopropyl-β□-D-thiogalactopyranoside (IPTG) at 37°C for 2 hours. The proteins were then purified in their native state on glutathione-Sepharose beads (GE Healthcare) according to a standard purification procedure. The eluted proteins were checked for purity and lack of degradation by 12% SDS-PAGE and Coomassie Blue staining, and they were stored in aliquots at −80°C until use.
+ Open protocol
+ Expand
8

Expression and Purification of SARS-CoV-2 Mpro

Check if the same lab product or an alternative is used in the 5 most similar protocols
A plasmid (pETM33_NSP5_Mpro; a gift from Ylva Ivarsson (Addgene plasmid # 156475; http://n2t.net/addgene:156475; RRID: Addgene_156475)) encoding the SARS-CoV-2 Mpro was transformed into Escherichia coli (E. coli) BL21-CodonPlus cells (Agilent Technologies). The protein was expressed upon induction with 0.1 mM isopropyl‐β‐D‐thiogalactopyranoside (IPTG) at 37 °C for 2.50 h. The cells were harvested by centrifugation (4000 g, 10 min, 4 °C) and the cell pellet was resuspended in 10 mL lysis buffer containing 50 mM Tris (pH 8), 300 mM NaCl, 10 mM β-mercaptoethanol (β-ME), 1 mM PMSF and 10 % (v/v) glycerol and lysed by sonication [21] , [22] , [26] , [27] (link). The supernatant was collected after centrifugation (18000 g, 90 min, 4 °C) and incubated with pre-equilibrated glutathione (GSH) beads at 4 °C for 2 h. The beads were washed with a buffer containing 50 mM Tris (pH 7), 150 mM NaCl, 10 mM β-ME, 1 mM EDTA, 0.01 % Triton X-100 % and 10 % glycerol. Following washes, the beads were incubated with the PreScission Protease (GE Healthcare #27–0843–01) in a buffer containing 50 mM Tris (pH 7), 150 mM NaCl, 1 mM DTT, 1 mM EDTA, 0.01 % Triton X-100 % and 10 % glycerol) at 4 °C for 16 h to cleave Mpro from the GST-tag. The supernatant containing SARS-CoV-2 Mpro protease was collected after centrifugation at 500 g at 4 °C for 10 min.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!